发明名称 |
Method for preventing HIV-1 infection of CD4 cells |
摘要 |
This invention provides methods for inhibiting fusion of HIV-1 to CD4<SUP>-</SUP> cells which comprise contacting CD4<SUP>-</SUP> cells with a non-chemokine agent capable of binding to a chemokine receptor in an amount and under conditions such that fusion of HIV-1 to the CD4<SUP>+</SUP> cells is inhibited. This invention also provides methods for inhibiting HIV-1 infection of CD4<SUP>-</SUP> cells which comprise contacting CD4<SUP>+</SUP> cells with a non-chemokine agent capable of binding to a chemokine receptor in an amount and under conditions such that fusion of HIV-1 to the CD4<SUP>+</SUP> cells is inhibited, thereby inhibiting the HIV-1 infection. This invention provides non-chemokine agents capable of binding to the chemokine receptor and inhibiting fusion of HIV-1 to CD4<SUP>+</SUP> cells. This invention also provides pharmaceutical compositions comprising an amount of the non-chemokine agent capable of binding to the chemokine receptor and inhibiting fusion of HIV-1 to CD4<SUP>+</SUP> cells effective to prevent fusion of HIV-1 to CD4<SUP>+</SUP> cells and a pharmaceutically acceptable carrier.
|
申请公布号 |
US2008187539(A1) |
申请公布日期 |
2008.08.07 |
申请号 |
US20070894677 |
申请日期 |
2007.08.20 |
申请人 |
PROGENICS PHARMACEUTICALS, INC. |
发明人 |
ALLAWAY GRAHAM P.;LITWIN VIRGINIA M.;MADDON PAUL J.;OLSON WILLIAM C. |
分类号 |
A61K39/395;A61P37/00;B65H3/02;B65H3/04;B65H3/52;C07K16/18;G01N33/566;G01N33/569 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|